Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly.
Aleksandra FranczakKatarzyna KolačkovAleksandra Jawiarczyk-PrzybyłowskaMarek BolanowskiPublished in: Pituitary (2018)
The risk-allele frequencies of studied polymorphisms in acromegaly were higher than in general European population. There is an association between FTO gene polymorphisms and HDL cholesterol concentration, suggesting FTO gene polymorphisms may be associated with higher CVD risk in patients with acromegaly.